SurModics (SRDX) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts SRDX Hot Sheet
Price: $42.98 --0%
Financial Fact:
Total operating costs and expenses: 14.07M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Total operating costs and expenses: 14.07M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
SurModics (NASDAQ: SRDX) reported Q3 EPS of ($0.17), in-line with the analyst estimate of ($0.17). Revenue for the quarter came in at $23.9 million versus the consensus estimate of $23.31 million.
GUIDANCE:
SurModics sees FY2021 EPS of $0.16-$0.31, versus the consensus of $0.25. SurModics sees FY2021 revenue of $103.5-105.5 million, versus the consensus of $103.5 million.
For earnings history and earnings-related data on SurModics (SRDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- HSBC Raises S&P500 Target to 8,100
- Mission Produce (AVO) Misses Q3 EPS by 2c; offers outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
